You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ocular hypertension

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)

Not yet recruiting
  • Glaucoma Open-Angle Primary
  • Ocular Hypertension
  • H-1337 0.6%
  • +3 more
  • Albany, Georgia
    Dixon Eye Care
Jun 12, 2023

Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

Not yet recruiting
  • Primary Open Angle Glaucoma (POAG)
  • +3 more
  • Experimental: QLS-111 ophthalmic solution, (0.015%)
  • +4 more
  • (no location specified)
Aug 30, 2023

Ocular Hypertension, Primary Open Angle Glaucoma Trial in Lackland Air Force Base (Nanodropper, Regular dropper)

Recruiting
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Nanodropper
  • Regular dropper
  • Lackland Air Force Base, Texas
    Wilford Hall Ambulatory Surgical Center
May 3, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Yerevan (iDose TR)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • iDose TR
  • Yerevan, Armenia
    Glaukos Clinical Study Site
Sep 25, 2023

Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Hypertension, Ocular
  • NCX 470
  • Latanoprost 0.005%
  • Austin, Texas
    Texan Eye
Nov 9, 2022

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)

Recruiting
  • Open Angle Glaucoma or Ocular Hypertension
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Oct 14, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide/brimonidine ophthalmic suspension, Simbrinza

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Brinzolamide/brimonidine ophthalmic suspension
  • Simbrinza 0.2%/1% Ophthalmic Suspension
  • Winston-Salem, North Carolina
    James D. Branch Ophthalmology
Aug 18, 2022

Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,

Active, not recruiting
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • Study Treatment 1 WB007
  • +3 more
  • Newport Beach, California
    Eye Research Foundation
Dec 30, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Melbourne (TO-O-1001, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Jul 11, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.065%, NCX 470 0.1%, Latanoprost 0.005%)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • NCX 470 0.065% (initial phase of trial)
  • +4 more
  • Newport Beach, California
    Eye Research Foundation
Oct 20, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic

Recruiting
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • SBI-100 Ophthalmic Emulsion, 0.5%
  • +2 more
  • Glendale, California
  • +2 more
Nov 17, 2023

Open-angle Glaucoma Trial in Yerevan (iStent inject, Travoprost)

Completed
  • Open-angle Glaucoma
  • Yerevan, Armenia
    S.V. Malayan Ophthalmological Center
Sep 2, 2022

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting
  • Cataract
  • +2 more
  • Bimatoprost Implant System (High Dose)
  • +4 more
  • Glendale, Arizona
    Arizona Advanced Eye Research Institute
Nov 8, 2023

Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Nebivolol Ophthalmic Suspension 1 Percent
  • +3 more
  • Newport Beach, California
    Site 0012
Jul 18, 2022

Ocular Hypertension Trial in Australia (FM101 tablet, FM101 oral solution, Placebo)

Recruiting
  • Ocular Hypertension
  • FM101 tablet
  • +4 more
  • Bella Vista, New South Wales, Australia
  • +4 more
Jul 18, 2022

Glaucoma, Ocular Hypertension Trial (Latanoprost eluting contact lens, Topical Latanoprost)

Not yet recruiting
  • Glaucoma
  • Ocular Hypertension
  • Latanoprost eluting contact lens
  • Topical Latanoprost
  • (no location specified)
Mar 15, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Seattle (Nanodropper adaptor, control)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Nanodropper adaptor
  • control
  • Seattle, Washington
    University of Washington
Mar 3, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (LL-BMT1)

Completed
Has Results
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Newport Beach, California
    Eye Research Foundatoin
Jun 7, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Albany (QLS-101, Timolol Maleate)

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Albany, Georgia
    Dixon Eye Care
May 3, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Te Aro, Rotorua (100ng/day PA5346 Latanoprost FA SR Ocular Implant)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 100ng/day PA5346 Latanoprost FA SR Ocular Implant
  • Te Aro, Wellington, New Zealand
  • +1 more
Apr 10, 2022

Glaucoma, Primary Open Angle, Ocular Hypertension Trial (TUG, Sham)

Terminated
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • TUG
  • Sham
  • (no location specified)
Mar 28, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022